LDLR and atherosclerosis: To achieve higher plasma cholesterol levels and thus larger atherosclerotic lesions that are comparable to current genetic knock-out mouse models of atherosclerosis (e.g. LDLR- and ApoE-deficient mice) we now used a combination of LDLR and SRB1 ASOs.